nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

31.10.2017 | Gynecologic Endocrinology and Reproductive Medicine

The role of serum ADAMTS-1 and aggrecan on polycystic ovary syndrome in adolescents and younger-aged females

verfasst von: Esra Nur Tola, Nadiye Dugan Koroglu, Serenat Eris Yalcin, Hilmi Baha Oral

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to analyze serum a disintegrin-like and metalloproteinase with thrombospondin-type motifs-1 (ADAMTS-1) and aggrecan levels in adolescents and younger-aged females with polycystic ovary syndrome (PCOS) compared with ovulatory controls to determine whether these are potential markers for the prediction of PCOS diagnosis. We also aimed to determine whether they could predict the development of clinical implications associated with PCOS.

Method

PCOS (n = 49) and ovulatory age-matched controls (n = 41) (mean age, 18.6 ± 2.5) were recruited. Anthropometric measurements were recorded and biochemical parameters were analyzed. Serum ADAMTS-1 and aggrecan levels were determined with enzyme-linked immunosorbent assay. The predictive effects of ADAMTS-1 and aggrecan on the diagnosis of PCOS and for the development of cardiovascular disease (CVD) risk and insulin resistance (IR) were evaluated. The correlation between investigated markers and anthropometric, biochemical, and hormonal parameters were also investigated.

Results

Mean serum ADAMTS-1 level was increased in adolescents and younger-aged females with PCOS compared to ovulatory controls. An elevated ADAMTS-1 level was positive predictive of the diagnosis of PCOS with the best cut-off value of 2.5 ng/ml (sensitivity 69% and specificity 78%). A positive predictive role of ADAMTS-1 on the development of CVD risk and IR was found among all patients. Serum ADAMTS-1 and aggrecan levels were significantly and positively correlated with each other.

Conclusion

Increased levels of ADAMTS-1 could be a potential marker for the etiopathogenesis of PCOS in adolescents and younger-aged females and predict the development of CVD risk and IR among all patients with the same age.

Lauritsen MP, Bentzen JG, Pinborg A et al (2014) The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod 29:791–801CrossRefPubMed

Li R, Zhang Q, Yang D et al (2013) Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 28:2562–2569CrossRefPubMed

Diamanti-Kandarakis E, Christakou C, Marinakis E (2012) Phenotypes and environmental factors: their influence in PCOS. Curr Pharm Des 18:270–282CrossRefPubMed

Corbett S, Morin-Papunen L (2013) The Polycystic Ovary Syndrome and recent human evolution. Mol Cell Endocrinol 373:39–50CrossRefPubMed

Russell DL, Robker RL (2007) Molecular mechanisms of ovulation: co-ordination through the cumulus complex. Hum Reprod Update 13:289–312CrossRefPubMed

Brown HM, Dunning KR, Robker RL et al (2010) ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice. Biol Reprod 83:549–557CrossRefPubMed

Ruder EH, Hartman TJ, Goldman MB (2009) Impact of oxidative stress on female fertility. Curr Opin Obstet Gynecol 21:219–222CrossRefPubMedPubMedCentral

Xiao S, Li Y, Li T et al (2014) Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients. J Clin Endocrinol Metab 99:E1015–E1021CrossRefPubMed

Doyle KM, Russell DL, Sriraman V et al (2004) Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor. Mol Endocrinol 18:2463–2478CrossRefPubMed

10.

Brown HM, Dunning KR, Robker RL et al (2006) Requirement for ADAMTS-1 in extracellular matrix remodeling during ovarian folliculogenesis and lymphangiogenesis. Dev Biol 300:699–709CrossRefPubMed

11.

Boerboom D, Russell DL, Richards JS et al (2003) Regulation of transcripts encoding ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs-1) and progesterone receptor by human chorionic gonadotropin in equine preovulatory follicles. J Mol Endocrinol 31:473–485CrossRefPubMed

12.

Russell DL, Ochsner SA, Hsieh M et al (2003) Hormone-regulated expression and localization of versican in the rodent ovary. Endocrinology 144:1020–1031CrossRefPubMed

13.

Stanton H, Melrose J, Little CB et al (2011) Proteoglycan degradation by the ADAMTS family of proteinases. Biochim Biophys Acta 812:1616–1629CrossRef

14.

Kuno K, Okada Y, Kawashima H et al (2000) ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 478:241–245CrossRefPubMed

15.

Yasuo T, Yamaguchi T, Kitaya K (2010) Progesterone induction of chondroitin sulfate proteoglycan aggrecan expression in human endometrial epithelial cells. J Steroid Biochem Mol Biol 122:159–163CrossRefPubMed

16.

Rotterdam E-S (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25

17.

Wiksten-Almstromer M, Hirschberg AL, Hagenfeldt K (2008) Prospective follow-up of menstrual disorders in adolescence and prognostic factors. Acta Obstet Gynecol Scand 87:1162–1168CrossRefPubMed

18.

Fruzzetti F, Perini D, Lazzarini V et al (2009) Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol 25:335–343CrossRefPubMed

19.

Witchel SF, Oberfield S, Rosenfield RL et al (2015) The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr 83:376–389CrossRef

20.

Keskin M, Kurtoglu S, Kendirci M et al (2005) Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115:e500–e503CrossRefPubMed

21.

Jellinger PS, Smith DA, Mehta AE et al (2012) American association of clinical endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 18:1–78CrossRefPubMed

22.

NCEP (1992) Expert Panel on Blood Cholesterol Levels in Children and Adolescents. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89:495–501

23.

Yung Y, Maman E, Konopnicki S et al (2010) ADAMTS-1: a new human ovulatory gene and a cumulus marker for fertilization capacity. Mol Cell Endocrinol 328:104–108CrossRefPubMed

24.

Karakose M, Demircan K, Tutal E et al (2016) Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome. J Endocrinol Invest 39:1269–1275CrossRefPubMed

25.

Ozler S, Oztas E, Tokmak A et al (2017) Role of versican and ADAMTS-1 in polycystic ovary syndrome. J Clin Res Pediatr Endocrinol 9:24–30CrossRefPubMedPubMedCentral

26.

Tola EN, Karatopuk DU, Koroglu N et al (2017) Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome. J Assist Reprod Genet 34:811–816CrossRefPubMed

27.

Eriksen GV, Malmstrom A, Uldbjerg N (1997) Human follicular fluid proteoglycans in relation to in vitro fertilization. Fertil Steril 68:791–798CrossRefPubMed

28.

Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645CrossRefPubMedPubMedCentral

29.

Boesgaard TW, Gjesing AP, Grarup N et al (2009) Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients–EUGENE2 study. PLoS One 4:e7236CrossRefPubMedPubMedCentral

30.

Artunc-Ulkumen B, Ulucay S, Pala HG, Cam S (2017) Maternal serum ADAMTS-9 levels in gestational diabetes: a pilot study. J Matern Fetal Neonatal Med 30(12):1442–1445CrossRefPubMed

31.

Jonsson-Rylander AC, Nilsson T, Fritsche-Danielson R et al (2005) Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 25:180–185PubMed

Titel: The role of serum ADAMTS-1 and aggrecan on polycystic ovary syndrome in adolescents and younger-aged females
verfasst von: Esra Nur Tola
Nadiye Dugan Koroglu
Serenat Eris Yalcin
Hilmi Baha Oral
Publikationsdatum: 31.10.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 2/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-017-4578-3

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

The role of serum ADAMTS-1 and aggrecan on polycystic ovary syndrome in adolescents and younger-aged females